Johns Hopkins Medicine Podcasts
2,000 FOLLOWERS
Each podcast is only about a minute, but provides nurses with the latest info in medicine. Johns Hopkins Medicine's weekly podcast looking at top medical stories of the week for people who want to become informed participants in their own health care.
Johns Hopkins Medicine Podcasts
2w ago
An injectable drug called omalizumab now may be used to manage severe food allergies, the FDA has decided. Robert Wood, an allergy expert at Johns Hopkins, says the drug will only work if people are taking it. Wood: This is …
Is lifelong treatment necessary with a drug to manage severe food allergies? Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
2w ago
Omalizumab is an injectable drug just approved by the FDA to treat severe food allergies. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says risks discerned in the …
Are there downsides to using omalizumab for treating food allergy? Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
2w ago
Consequences of food allergies can be life-threatening, which is why FDA approval of omalizumab to treat them is welcome. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says …
Are food allergies becoming more common? Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
2w ago
Feeding very young children peanut products can assure that they don’t develop an allergy to peanut. Can this strategy be expanded to allergies to foods like milk, meat, or egg? Johns Hopkins allergy expert Robert Wood comments. Wood: There’s an enormous …
Can early feeding of allergenic foods overcome them? Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
2w ago
Can food allergies be outgrown? Elizabeth Tracey reports Most people know about peanut allergy, since it impacts a lot of people, especially children. Can these allergies be outgrown? Robert Wood, an allergy expert at Johns Hopkins, says for most, that’s …
Hnf040124 Read More ..read more
Johns Hopkins Medicine Podcasts
3w ago
If you have a severe allergy to one food, you probably have the same issues with other foods, as well as allergies to things like pollen that you inhale. That’s according to Robert Wood, principal investigator on a study that …
Severe food allergies do not usually occur alone, Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
3w ago
Food allergies are very often multiple and begin in childhood. Does this mean the newly approved omalizumab, given by injection, must be taken for the rest of someone’s life? Robert Wood, principal investigator on the study used by the FDA …
Are injections to keep food allergies under control a lifelong prospect? Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
3w ago
The FDA has just approved a drug called omalizumab used to treat asthma to treat multiple, severe food allergy. Robert Wood, an allergy expert at Johns Hopkins and principal investigator on the study that demonstrated the drug’s efficacy, says the …
Having allergies to many foods may make using a newly approved drug practical, Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
3w ago
A drug called omalizumab has just been approved to treat severe food allergies. Robert Wood, Johns Hopkins allergy expert and principal investigator on a study proving the efficacy of this drug, says it’s needed because the strategy of feeding increasing …
Can food allergies be overcome by feeding foods people are allergic to? Elizabeth Tracey reports Read More ..read more
Johns Hopkins Medicine Podcasts
3w ago
Omalizumab is the chemical name for Xolair, an asthma medication that’s been around for decades that has just gotten FDA approval to treat food allergy. Robert Wood, an allergy expert at Johns Hopkins and one author of a recent study …
A newly approved drug to treat food allergy may be a game changer, Elizabeth Tracey reports Read More ..read more